nous leukemia (CML) is characterized by metamorphosis of the chronic phase t o blastic crisis. However, cellular events associated with this transition are poorly understood. To examine the possible participation of hematopoietic growth factors in this process, we studied growth factor expression in adherent layers of bone marrows derived from CML Ph' patients in various stages of the disease. Interleukin-1 p (IL-1p) and IL-6 mRNA were expressed in five of six patients, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in one of six patients with myeloid/undifferentiated blast crisis. In addition, leukemia inhibitory factor (LIF) expression was increased in four of six patients with myeloid/ undifferentiated blast crisis phase of the disease. IL-1p was also detected in bone marrow adherent layer conditioned medium from two of these patients. These results were in sharp contrast t o the lack of detectable levels of uninduced IL-lp, IL-6, and GM-CSF mRNA, in samples derived from 4 HRONIC MYELOGENOUS leukemia (CML) is a C paradigm of tumor progression. The disease starts in a chronic phase characterized by marked hyperplasia of myeloid cells that maintain their maturation capacity, and is easily controlled with therapy.',' This is followed by an accelerated phase in which the myeloid cells gradually lose their capacity for terminal differentiation. Basophilia, thrombocytosis, and cytogenetic clonal evolutions also appear. Finally, the disease terminates in a blastic phase, which is characterized by the rapid accumulation of cells that retain a "blast" morphology and is highly resistant to thera~y.33~ Blastic crisis can be classified as myeloid, lymphoid, or undifferentiated, based on morphologic, cytochemical, and immunologic features of the cell^.^^^ Genetic instability of the malignant clone is a characteristic of CML? Although the chronic phase is characterized in most cases by the Philadelphia chromosome (Ph) and the resultant BCR-ABL hybrid it is generally believed that acquisition of additional genetic molecular abnormalities within the malignant clone herald phenotypic transformation. However, the information on specific acquired patients in lymphoid blastic crisis, 3 in accelerated, and 11 in chronic phases of the disease, or from normal controls. The possibility of a paracrine loop formation, whereby the adherent layers representing the bone marrow stroma are induced t o express hematopoietic growth factors, was supported by our finding IL-1s mRNA expression in the leukemic blast cells in three of four studied patients in blast crisis and IL-lp protein production in seven of eight patients studied. Finally, coculturing CML blast crisis cells onto pre-established adherent layers induced the expression of both IL-lp and IL-6 genes. From this preliminary study, it appears that abnormal expression of growth factors is a common event with CML Ph' progression. We hypothesize that IL-1p generated by the transformed malignant clone stimulates the marrow stroma t o produce various growth factors, and that this process may play a role in disease progression. Long-term bone marrow culture, developed by Dexter and Lajtha in 1974, provides a means to examine the interplay between hematopoietic cells and bone marrow stroma. 15 The adherent layer in such a system modulates in vitro long-term hematop~iesis'~*'~ and therefore appears to possess part of the regulatory "machinery" that maintains blood cell production. To date, there has been no data accrued which suggest bone marrow stromal involvement in CML progression. In this report we provide evidence for such changes occurring in the advanced stages of the disease.
MATERIALS AND METHODS
Bone marrow samples from normal donors and CML Philadelphia chromosome' positive (Ph') patients were obtained by posterior iliac crest aspirations after skin infiltration with 0.5% lidocaine for local anesthesia. Control samples were taken from untreated metastatic breast cancer patients without marrow involvement when marrow was collected for autologous transplantation. Sample collections were performed at M.D. Anderson Cancer Center (Houston, TX) in accordance with institutional guidelines, and following obtaining an informed consent from all participants. Light-density bone marrow cells and peripheral blood cells were isolated on 1.077 g/mL Ficoll-Hypaque gradient (Pharmacia Fine Chemicals, Piscataway, NJ; Wintrop Laboratories, New York, NY) centrifugation.
To avoid activation by purification procedure, samples were lysed with 1.22% ammonium oxalate and cell pellets collected. For granulocyte and lymphocyte purification, cells were further separated on Percoll (Pharmacia) discontinuous gradient.
The bone marrow cultures were established to support the adherent layers only." Bone marrow cells were suspended at final plating concentration of 5 X l@lmL in 150175 cmz tissue culture flasks (Corning Glass Works, Corning,
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air environment with complete replacement of medium weekly with the removal, at each medium change, of all nonadherent cells. When cultures reached confluency (between 4 and 6 weeks), they were washed twice with Ca2+/M&+-free phosphate-buffered saline (GIBCO, Santa Clara, CA) to remove loosely adherent cells and treated with 0.25% trypsin (GIBCO)."
These experiments were designed to study the effect of the CML cells on stromal elements. Accordingly, 5 x 105 peripheral blood cells from patient F, with mixed phenotype blasts (Table l) , and from a patient in chronic phase were seeded onto adherent As control, the preestablished layers were maintained without the addition of the peripheral blood cells to test whether the prolonged incubation will affect cytokine expression. In addition, cultures were established from the peripheral blood cells without the support of adherent cells. The cultures were treated once a week by removal of all of the growth medium, including the nonadherent cells, and the addition of fresh medium. Cultured adherent layer cells were harvested after 3 weeks of coculturing. Subsequently, the adherent cells were analyzed for mRNA expression and DNA was extracted for bcr rearrangement studies.
To define the cellular characteristics of the blastic crisis cells, biochemical and enzymatic stains were used, as previously described?16 Myeloperoxidase-positive cells were classified as myeloid blast crisis. Also, a peroxidase-negative but chloroacetate or nonspecific esterasepositive blast cells were classified as myeloid. Peroxidase-negative terminal deoxy nucleotidyl transferase (TdT) enzyme-positive blast cells were categorized as lymphoid blasts, whereas undifferentiated blast cells could not be categorized on that basis of cytochemical analysis.
The molecular hallmark of CML Phl is the aberrant genomic configuration: bcr rearrangement.' Therefore, to evaluate the presence of leukemic hematopoietic cells in the adherent layers bone marrow cultures, DNA was prepared, as previously described," from CML Ph' hematopoietic cells in blastic crisis and from the cultured adherent layers of the same patients. Ten micrograms of DNA was digested with BamHI and BglII restriction endonucleases in conditions recommended by the supplier of the endonucleases (International Biotechnologies, Inc, New Haven, CT), electrophoresed in 0.8% agarose gel, blotted, and hybridized according to the method of Southemu The universal probe (Ph'/bcr-3' probe) was obtained from Oncogene Science, Inc (Manhasset, NY) and labeled by oligoprimer extenCoculture experiments.
Morphologic cytochemical diagnosis of blast cells.
Analysis of bcr rearrangement studies. ++, 21% to 50% of the maximum; +, 1% to 20% of the maximum.
GM-CSF
sion to a specific activity of 1 to 3 x lo9 cpm/microgram of DNA?' After hybridization, the filters were washed at 60°C for 1 hour in 0.1X SSC solution (SSC = 0.15 mol/L sodium chloride, 0.015 mol/L sodium citrate) containing 0.1% sodium dodecyl sulfate, dried, and autoradiographed.
To examine whether small numbers of CML Ph' positive cells reside in the adherent layers, we analyzed cDNA synthesized from these layers for the expression of bcr exon 3-ABL exon 2 and bcr exon 2-AI3L exon 2 junctions, respectively, by polymerase chain reaction, as previously described.z
To analyze interleukin-la (IL-la), IL-lp, IL-6, granulocyte-macrophage colony-stimulation factor (GM-CSF), granulocyte-CSF (G-CSF), monocyte-CSF (M-CSF), leukemia inhibitory factor (LIF), transforming growth factor @, (TGF-@,), tumor necrosis factor-a (TNF-a), and IL-3 mRNA expression, adherent and leukemic cells were lysed with 4 mol/L guanidinium isothiocyanate (Bethesda Research Laboratories, Bethesda, MD) solution,26 and total RNA was prepared. To prepare a positive control for IL-la, IL-l@, IL-6, GM-CSF, G-CSF, M-CSF, LIF, TGF-PI, and TNF-a expression, RNA was extracted from fresh peripheral blood mononuclear cells isolated on 1.077 g/mL Ficoll-Hypaque density gradient centrifugation and cultured with 1% phytohemagglutinin (GIBCO) for 24 hours at 37°C under humidified 5% C0,-in-air conditions. The 5637 bladder carcinoma cell line (American Type Culture Collection [ATCC], Rockville, MD) expresses IL-3 and served as control for this cytokine expression." Total RNA derived from adherent layer cells (40 kg per lane) and poly (A)' selected" mRNA (4 pg per lane) from leukemic cells were size separated in 1% agarose/formaldehyde gels, transferred to nitrocellulose filters, and hybridized to 32P-labeled cDNA probes. Preparation of cDNA probes and hybridization conditions used for the Northern analysis have been previously described." The relative density of the signals was determined by laser densitometry using the Jojce Loebl Densitometer, Ephoretic (Vickers Instruments Inc, Maiden, MA). The results are presented as percentage of maximum, after subtracting the reading of a chronic phase sample, from the blastic crisis sample performed on the same blot.
To demonstrate IL-1@ protein in the adherent layers, the confluent adherent layers were refed with the standard culture medium 24 hours before harvesting, and 24 hours later the conditioned medium was pooled and 10-fold concentrated with an Amicon apparatus (Amicon Corp, Danvers, MA). To demonstrate IL-1s protein in fresh leukemic cells, peripheral blood cells, bone marrow cells, granulocytes, and lymphocytes were freezed and thawed three times in low-concentration phosphate-buffered saline, and supernatants were pooled. All samples were studied in duplicates by an ELISA kit (Cistron, Pine Brook, NJ) which uses a monoclonal antibody specific for IL-lB. The assay was read in a Molecular Devices' microplate reader (Palo Alto, CA).
c-DNA probes for human (h) GM-CSF, hG-CSF, hIL-la and hIL-l@, hIL-3 (COS Lab, Denton, TX), hLIF, hTGF-PI, hIL-6 (Genentech Inc, South San Francisco, CA), hM-CSF (Genetics Institute, Cambridge, MA), hTNF-a, and @-actin (ATCC) have been previously described.M-'' Expression of cytokines.
IL-I$ enzyme-linked immunosorbent assay (ELISA).
DNAprobes.
RESULTS
Variations in conditions used to establish long-term bone marrow cultures result in differences in the pattern of hematopoiesis observed. We have previously examined bone marrow adherent layer cultures under conditions optimal for myelopoiesis, which require horse serum and methylprednisolone,a or Bone marrow culture conditions.
For
B lymphopoiesis, which require fetal calf serum."' We found no differences regarding morphologic, cytochemical, or antigenic characteristics."* We have since studied bone marrow culture with fetal calf serum only, because under these conditions hematopoiesis decreases rapidly," enabling us to study the adherent layer itself. Formation of the adherent layer was consistent with rapid cell number decrease during the first week, followed by steady increase through week 5, when confluency was reached. This method was applied to study bone marrow adherent layers from 10 blastic crisis, 3 accelerated-phase, and 11 chronic-phase CML Ph' patients.
Coculture experiments. Low-density mononuclear cells obtained from patient F (Table 1) in blast crisis and from a patient in the chronic phase were seeded onto preestablished adherent layers derived from a normal donor. In neither case did the cells localize in the adherent layers or proliferate in culture, as observed by inverted microscopy. In addition, no cells were found in the nonadherent component of the culture after the first medium removal. Cultures established from the peripheral blood cells without the support of adherent layers died out after the first medium removal.
Mophobgzc diagnosis of the leukemic cells. Patients A through C (Table 1) were classified to have undifferentiated blast crisis, and patients D and E were classified as having myeloid blastic crisis. Patient F was classified in mixed phenotype blast crisis, and patients G through J were classified in lymphoid blast crisis.
Analysis of bcr rearrangement studies. bcr rearrangement was not found in DNA derived from the adherent layers of patients A and D (data not shown) or in stromal cell DNA derived from 10 chronic-phase CML, whereas DNA extracted from the leukemic cells of the corresponding patients showed bcr rearrangement with two restriction endonucleases (data not shown). Unfortunately, no DNA was available on the other blast crisis patients. Likewise, no bcr rearrangement was found in the adherent layers derived from the coculture experiments (Fig 1) . Because about 1% to 5% of bcr rearrangement-positive cells can be detected by this methodol~gy,~"~ we used the polymerase chain reaction technique to show that the mRNA coding for bcr exon 2-ABL exon 3 was detected in the adherent layer derived from the multure experiment (data not shown). These results suggest that Ph'-positive hematopoietic progenitors constitute only a very small proportion ( < 1% to 5%) of the population present in the adherent layer.
Cytokine mRNA expression in blastic crisis adherent layer cells. IL-lf3 mRNA was expressed in five of six adherent layers established from CML myeloid/undifferentiated blastic crisis samples (Fig 2) . patients A through D, and F. In contrast, IL-lp was not discerned in adherent layers established from four individuals with lymphoid blastic crisis, nor from the 3 accelerated-phase, 11 chronic-phase, and 11 normal patient samples. Similarly, I L 6 mRNA was expressed in adherent layers of five patients in myeloid/ undifferentiated blast crisis (A through D, and F), but not in the adherent layers of normal individuals nor in those of chronic-or accelerated-phase patients (Fig 3) . Interestingly, the patient with undifferentiated blastic crisis who had increased ILlf3 expression also showed significantly increased LIF expression as compared with the chronicphase patients (Fig 4) . TNF-a, IL-3, I L l a , or G-CSF were not detected in any of our samples, whereas TGF-f3, and M-CSF mRNA were constitutively and equally expressed in chronic, accelerated, and blastic crisis CML, as well as in the adherent layer established from normal bone marrow (data not shown). No significant differences in f3-actin signal intensity were observed, indicating that: (1) equal amounts of RNA had been loaded onto each lane, and (2) no RNA degradation has occurred (data not shown).
Bone marrow adherent cells from the multure experia ments with cells derived from patient F (Table 1) expressed IL-If3 (data not shown) and IL-6 mRNA (Fig 5, lane l) , whereas control cultures with the same adherent layers maintained for the same length of time did not express these genes (Fig 5, lane 2) . Likewise, the adherent layers cocultured with hematopoietic cells from a patient in the chronic phase did not express IL-lf3 or IL-6. In addition, both perturbed and control adherent layers expressed TGFB,, M-CSF, and LIF, whereas T N F a , IL-3, IL-la, and G-CSF were not detected. No significant differences in @actin signal intensity were observed (Fig 5B) .
IL-If3 protein secretion from the bone m a m w cultures. Patients A and B, who expressed the highest IL-lf3 mRNA levels, had 50 pg/mL and 17 pg/mL of IL-1 f3 protein in 1OX concentrated conditioned medium. IL-lf3 protein was not discerned in the media from any other patient, including the three other patients who also expressed IL-lf3 mRNA, probably because the protein levels were below the limits of sensitivity of this assay.
Cytokine expression and production in the hematopietic blast celk. IL-If3 mRNA was expressed in peripheral blood leukemic cells of three (A, B, and C) of four (A through D) patients in myeloid/undifferentiated blastic crisis, while none expressed G-CSF, GM-CSF, IL-la, LIF, or IL-6 (data not shown). No hematopoietic cells were available on any of the other patients for mRNA evaluation. However, cell pellets were available from patients A through C and E through H for protein determination. Interestingly, patients A and B and E through H (Table 1) produced high levels of IL-lf3 ranging from 500 to 1, OOO pg/2.4 x lo7 cells. Patient C produced 14 pg/2.4 X lo7 cells of IL-16. All patients in blastic crisis had 60% to 90% blasts in their peripheral blood at the time of sample collection; no correlation was found between blast percentage and IL-lf3 levels.47 Twenty-five normal controls, including nor- For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From mal bone marrows, lymphocytes, and granulocytes, ranged between 0 and 95 pg/2.4 X lo7 cells, with a mean 2 2 SD of 28.8 _t 54 pg12.4 x lo7 cells.
DISCUSSION
Interactions between hematopoietic stem cells and the bone marrow microenvironment play a major role in the proliferation and differentiation of blood cells. The present system was devised to evaluate the possible role of the microenvironment in myeloproliferative disorder progression. The fact that stromal cells produce growth factors, either uninduced or after stimulation, is known. Clonal cell lines derived from murine bone marrow stroma were found to produce pre-B cell growth factor(^),^.^^ and human stromal cells were found to produce TGF-pIM and M-CSF. 42 Normal human bone marrow fibroblast-conditioned medium suppresses proliferation of undifferentiated leukemia cells and stimulates growth of differentiated (M2 of FrenchAmerican-British classification) leukemia cells.51 Furthermore, we have previously shown that adherent layers from CML patients in the chronic phase are indistinguishable from normal adherent layers."
The significance of our current results lies in the differences in stromal growth factor expression between the various forms of CML blast crisis and the various stages of the disease. Adherent layers derived from myeloid/ undifferentiated blast crisis phase expressed IL-lp, IL-6, and GM-CSF, and showed increased expression of LIF, but adherent layers derived from lymphoid blastic crisis, accelerated-phase, and chronic-phase bone marrow samples did not.
Of particular importance is the expression of IL-1s. This cytokine has pleiotropic activities, among which are induction of cytokines and adhesion molecules in fibroblasts and endothelial cellsSZ and increased expression of class I major histocompatibility complex ar1tigens.5~ It is also a potent inducer of hematopoietic growth factor expression in bone marrow adherent layers4' and augments its own expresion.'^ A possible role for IL-1p in the pathogenesis of myeloid neoplasia was first suggested with the detection of its secretion by some acute myelogenous leukemia ~e l l s . 2~~~~ Here we show that bone marrow adherent cells from patients in myeloid/undifferentiated blast crisis express IL-lp, whereas adherent layers from patients in the chronic phase of the disease or from normal controls do not express IL-lp."' Furthermore, the finding that Phl-positive leukemic cells constitute less than 1% to 5% of the adherent layers, as determined by Southern blotting and polymerase chain reaction, indicates that IL-lp gene expression was derived from the adherent layers themselves and not from the hematopoietic cells residing in the adherent layer. Therefore, we conclude that either the neoplastic hematopoietic cells produce molecules that activate the adherent layer cells to release various cytokines or that the adherent layer cells are inherently defective in advanced disease. The first possibility is supported by the finding that IL-lp expression could be induced in normal adherent layers cocultured for 1 week with the leukemic cells derived from a patient in blastic crisis. The second possibility, which we feel is less likely, nevertheless derives some support from findings in the literature that tumor stromal cells can acquire malignant phenotypic characteristics, ie, the stroma of cervical tumors has been previously observed to have some dysregulated growth patterns and a decreased serum dependen~y.'~ In addition, human tumor cell lines in culture have been found to release TGFs that confer the transformed phenotype on untransformed fibroblast~.5~,'~ The other growth factors that are expressed in the blastic crisis adherent layers might have been induced by IL-lp as the initial For instance, we have recently shown that LIF is constitutively expressed in adherent layers from normal volunteers, and that this expression can be significantly increased by exposure to IL-lp.& Interestingly, in our system exposure of adherent layers derived from normal volunteers or chronic-phase CML patients to IL-1p results in induction of G-CSF, but not GM-CSF, mRNA.4' The presence of GM-CSF, but not G-CSF, message in our IL-1p-producing adherent layers from a blast crisis patient is unexplained, but could further reflect a perturbed growth factor expression pattern of these cells that is related to the disease process. Each induced cytokine may have an independent role in modulating hematopoiesis. For instance, infection of a factor-dependent murine cell line with a retroviral construct containing the GM-CSF cDNA led to the emergence of autonomous, GM-CSF-producing sublines that were uniformly leukemogenic when transplanted to syngeneic recipient^.^^ IL-6 provides a proliferative stimulus to several types of hematopoietic cells and may act as a growth factor in multiple myeloma."4z Finally, LIF inhibits growth and induces macrophage differentiation of the M1 leukemic cell line,63 but stimulates growth of IL-3-dependent DA-1 leukemic cells.@ Our results showing expression of IL-lp, IL-6, and GM-CSF and increased expression of LIF mRNA in adherent layers established from blastic crisis CML possibly suggest a new mechanism of CML progression. This model envisages the leukemic cells to be in intimate contact with regulatory stromal cells of nonhematopoietic mesenchymal origin. Factors generated by the leukemic cells may influence the activity of the microenvironment and, in turn, direct interactions between the regulatory mesenchymal cells, and the leukemic cells determine the proliferative and differentiation state of the latter. The fact that samples derived from lymphoid blastic crisis patients were devoid of growth factor expression, which was detected in the myeloid blastic crisis samples, suggests that disease progression in the various phenotypic subsets of the disease may be governed by a different mechanism.
Finally, it has been recently shown that, in allogeneic marrow transplantation, host bone marrow stromal cells may regenerate and repopulate the bone or exist for protracted periods after transplantation.66 Our current results, suggesting a possible role for the stroma in blastic crisis phase of CML, might also provide an explanation for the poor results of marrow transplantation in this phase of the disease.67 For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From
